Nos publications
Mise à jour août 2024
Pagination
- Page précédente
- Page 11
- Page suivante
Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Novel Mechanisms of Thrombopoietin Generation: The Essential Role of Kupffer Cells | Karakas D, Li J, Ni H | 2021 | Blood | View Novel Mechanisms of Thrombopoietin Generation: The Essential Role of Kupffer Cells | Researchers | Basic research |
Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein | Greinacher A, Selleng K, Mayerle J, Palankar R, Wesche J, Reiche S, Aebischer A, Warkentin TE, Muenchhoff M, Hellmuth JC, Keppler OT, Duerschmied D, Lother A, Rieg S, Gawaz MP, Mueller KAL, Scheer CS, Napp M, Hahnenkamp K, Lucchese G, Vogelgesang A, Flöel A, Lovreglio P, Stufano A, Marschalek R, Thiele T | 2021 | Blood | View Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein | Researchers | Clinical research |
Buffy coat platelets coming to America: Are we ready? | Gammon RR, Devine D, Katz LM, Quinley E, Wu Y, Rowe K, Razatos A, Min K, Reichenberg S, Smith R | 2021 | Transfusion | View Buffy coat platelets coming to America: Are we ready? | Blood operators | New or improved product or process |
Efficacy and safety of tranexamic acid in acute traumatic brain injury: a systematic review and meta-analysis of randomized-controlled trials | Lawati KA, Sharif S, Maqbali SA, Rimawi HA, Petrosoniak A, Belley-Cote EP, Sharma SV, Morgenstern J, Fernando SM, Owen JJ, Zeller M, Quinlan D, Alhazzani W, Rochwerg B | 2021 | Intensive Care Med | Researchers | Clinical research | |
Identification of an alpha-1 antitrypsin variant with enhanced specificity for factor XIa by phage display, bacterial expression, and combinatorial mutagenesis | Bhakta V, Hamada M, Nouanesengsy A, Lapierre J, Perruzza DL, Sheffield WP | 2021 | Sci Rep | View Identification of an alpha-1 antitrypsin variant with enhanced specificity for factor XIa by phage display, bacterial expression, and combinatorial mutagenesis | Researchers | Basic research |
Multimerin 1 supports platelet function in vivo and binds to specific GPAGPOGPX motifs in fibrillar collagens that enhance platelet adhesion | Leatherdale A, Parker DA, Tasneem S, Wang Y, Bihan D, Bonna A, Hamaia SW, Gross PL, Ni H, Doble BW, Lillicrap D, Farndale RW, Hayward CPM | 2021 | J Thromb Haemost | View Multimerin 1 supports platelet function in vivo and binds to specific GPAGPOGPX motifs in fibrillar collagens that enhance platelet adhesion | Researchers | Basic research |
Research initiatives of blood services worldwide in response to the covid-19 pandemic | O'Brien SF, Lieshout-Krikke RW, Lewin A, Erikstrup C, Steele WR, Uzicanin S, Custer B, the Surveillance RA, Policy Sub-group of the ISBT Transfusion Transmitted Infectious Diseases Working Party | 2021 | Vox Sang | View Research initiatives of blood services worldwide in response to the covid-19 pandemic | Researchers | Clinical research |
Systematic review and meta-analysis of outcomes in patients with suspected pulmonary embolism | Patel P, Patel P, Bhatt M, Braun C, Begum H, Nieuwlaat R, Khatib R, Martins CC, Zhang Y, Etxeandia-Ikobaltzeta I, Varghese J, Alturkmani H, Bahaj W, Baig M, Kehar R, Mustafa A, Ponnapureddy R, Sethi A, Thomas M, Wooldridge D, Lim W, Bates SM, Lang E, Le Gal G, Haramati LB, Kline J, Righini M, Wiercioch W, Schünemann H, Mustafa RA | 2021 | Blood Adv | View Systematic review and meta-analysis of outcomes in patients with suspected pulmonary embolism | Researchers | Clinical research |
In vitro assessment and phase I randomized clinical trial of anfibatide a snake venom derived anti-thrombotic agent targeting human platelet GPIb? | Li BX, Dai X, Xu XR, Adili R, Neves MAD, Lei X, Shen C, Zhu G, Wang Y, Zhou H, Hou Y, Ni T, Pasman Y, Yang Z, Qian F, Zhao Y, Gao Y, Liu J, Teng M, Marshall AH, Cerenzia EG, Li ML, Ni H | 2021 | Sci Rep | View In vitro assessment and phase I randomized clinical trial of anfibatide a snake venom derived anti-thrombotic agent targeting human platelet GPIb? | Researchers | Clinical research |
Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects | Huynh A, Arnold DM, Smith JW, Moore JC, Zhang A, Chagla Z, Harvey BJ, Stacey HD, Ang JC, Clare R, Ivetic N, Chetty VT, Bowdish DME, Miller MS, Kelton JG, Nazy I | 2021 | Viruses | View Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects | Researchers | Clinical research |
An international comparison of HIV prevalence and incidence in blood donors and general population: a BEST Collaborative study | Germain M, Grégoire Y, Custer BS, Goldman M, Bravo M, Kamel H, Davison K, Field S, van den Hurk K, van de Laar TJW, Irving DO, Jones A, Liumbruno G, Morley S, O’Brien SF, Pillonel J, Steinsvåg CT, Takanashi M, Tsuno NH, Vesga Carasa MA, Wendel S, Vassallo RR, Tiberghien P, for the BEST Collaborative | 2021 | Vox Sang | View An international comparison of HIV prevalence and incidence in blood donors and general population: a BEST Collaborative study | Researchers | Benchmarking and standard setting |
Concentré de recherche: L’administration d’albumine par voie intraveineuse ne conduit pas à de meilleurs résultats chez les personnes subissant des opérations cardiaques | Bartoszko J | 2021 | Blood.ca website | View Concentré de recherche: L’administration d’albumine par voie intraveineuse ne conduit pas à de meilleurs résultats chez les personnes subissant des opérations cardiaques | Health care providers | Clinical research |
International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Responses | Goldman M, Townsend M, Magnussen K, Lozano M, Nissen-Meyer LSH, Lee CK, Leung JN, Takanashi M, McKay J, Kvist M, Robitaille N, Deschênes J, Di Angelantonio E, McMahon A, Roberts D, Maghsudlu M, Castrén J, Tiberghien P, Woimant G, Morel P, Kamel H, Bravo M, Shinar E, Gendelman V, Raz H, Wendel S, Fachini R, Quee F, van den Hurk K, Wiersum J, Grima KM, Speedy J, Bruun MT, Dunbar NM | 2021 | Vox Sang | View International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Responses | Health care providers | Benchmarking and standard setting |
Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia | Viana R, D'Alessio D, Grant L, Cooper N, Arnold D, Morgan M, Provan D, Cuker A, Hill QA, Tomiyama Y, Ghanima W | 2021 | Adv Ther | View Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia | Researchers | Clinical research |
Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology | Sirotich E, Guyatt G, Gabe C, Ye Z, Beck CE, Breakey V, Cooper N, Cuker A, Charness J, de Wit K, DiRaimo J, Fein SG, Grace RF, Hassan Z, Jamula E, Kang M, Manski CF, O'Connor C, Pai M, Paynter D, Porter SC, Pruitt B, Strachan G, Webert KE, Yan JW, Kelton JG, Bakchoul T, Arnold DM | 2021 | J Thromb Haemost | View Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology | Health care providers | Benchmarking and standard setting |
Risk of transfusion-transmitted Babesia microti in Canada | O'Brien SF, Drews SJ, Yi Q-L, Bloch EM, Ogden NH, Koffi JK, Lindsay LR, Gregoire Y, Delage G | 2021 | Transfusion | View Risk of transfusion-transmitted Babesia microti in Canada | Researchers | Benchmarking and standard setting |
Réactions transfusionnelles anaphylactiques et déficit en IgA | Khandelwal A, Clarke G, Goldman M | 2021 | Blood.ca website | View Réactions transfusionnelles anaphylactiques et déficit en IgA | Health care providers | Benchmarking and standard setting |
Factors associated with wrong blood in tube errors: An international case series - The BEST collaborative study | Dunbar NM, Kaufman RM | 2021 | Transfusion | View Factors associated with wrong blood in tube errors: An international case series - The BEST collaborative study | Health care providers | Benchmarking and standard setting |
Monocyte monolayer assay predictions of clinical outcome for serologically incompatible red blood cells is all about timing | Branch DR, Sandhu G, Raos M | 2021 | Transfusion | View Monocyte monolayer assay predictions of clinical outcome for serologically incompatible red blood cells is all about timing | Researchers | New or improved product or process |
Lessons learned in the collection of convalescent plasma during the COVID-19 pandemic | Wendel S, Land K, Devine DV, Daly J, Bazin R, Tiberghien P, Lee C-K, Arora S, Patidar GK, Khillan K, Smid WM, Vrielink H, Oreh A, Al-Riyami AZ, Hindawi S, Vermeulen M, Louw V, Burnouf T, Bloch EM, Goel R, Townsend M, So-Osman C | 2021 | Vox Sang | View Lessons learned in the collection of convalescent plasma during the COVID-19 pandemic | Blood operators | New or improved product or process |
Chapter 11: Massive hemorrhage and emergency transfusion | Trudeau J, Dawe P, Shih A | 2021 | Clinical Guide to Transfusion | View Chapter 11: Massive hemorrhage and emergency transfusion | Health care providers | Benchmarking and standard setting |
Current challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence studies among blood donors: A scoping review | Saeed S, Uzicanin S, Lewin A, Lieshout-Krikke R, Faddy H, Erikstrup C, Osiowy C, Seed C, Steele W, Davidson K, Custer B, O’Brien S, Assessment ObotSR, Policy sub-group of the Transfusion Transmitted Infectious Diseases Working Party of the International Society of Blood Transfusion | 2021 | medRxiv | View Current challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence studies among blood donors: A scoping review | Researchers | Basic research |
International Forum on Walking Blood Bank Programmes: Summary | Martinaud C, Scorer T, Lozano M, Miles A, Fitchett G, Ba A, Wikman A, Nimberger-Hansson P, Enbuske S, Bohon?k M, Devine D, Beckett AN, Mbanya D, T'Sas F, Degueldre J, Chueca M, Dedome E, Apelseth T, Strandenes G, Wendel S, Fachini R, Olszewski A, Dupont C, Glassberg E, Shinar E, Taylor AL, Corley JB, Sekaran Nadarajan V, Dunbar N | 2021 | Vox Sang | View International Forum on Walking Blood Bank Programmes: Summary | Blood operators | Benchmarking and standard setting |
CD248 enhances tissue factor procoagulant function, promoting arterial and venous thrombosis in mouse models | Kapopara PR, Safikhan NS, Huang JL, Meixner SC, Gonzalez K, Loghmani H, Ruf W, Mast AE, Lei V, Pryzdial ELG, Conway EM | 2021 | J Thromb Haemost | View CD248 enhances tissue factor procoagulant function, promoting arterial and venous thrombosis in mouse models | Researchers | Basic research |
Rethinking platelet transfusion practices | Devine DV | 2021 | Blood | View Rethinking platelet transfusion practices | Health care providers | New or improved product or process |
Convalescent plasma for hospitalized patients with COVID-19 and the effect of plasma antibodies: a randomized controlled, open-label trial | Bégin P, Callum J, Jamula E, Cook R, Heddle NM, Tinmouth A, Zeller MP, Beaudoin-Bussières G, Amorim L, Bazin R, Loftsgard KC, Carl R, Chassé M, Cushing MM, Daneman N, Devine DV, Dumaresq J, Fergusson DA, Gabe C, Glesby MJ, Li N, Liu Y, McGeer A, Robitaille N, Sachais BS, Scales DC, Schwartz L, Shehata N, Turgeon AF, Wood H, Zarychanski R, Finzi A, Arnold DM, for The CONCOR-1 Study Group | 2021 | medRxiv | View Convalescent plasma for hospitalized patients with COVID-19 and the effect of plasma antibodies: a randomized controlled, open-label trial | Health care providers | Clinical research |
Necrotizing enterocolitis and mortality after transfusion of ABO non-identical blood | Parvizian MK, Barty R, Heddle NM, Li N, McDougall T, Mukerji A, Fusch C, Solh Z | 2021 | Transfusion | View Necrotizing enterocolitis and mortality after transfusion of ABO non-identical blood | Researchers | Clinical research |
Mechanism of increased efficacy of recombinant Fc-?TP-L309C compared to IVIg to ameliorate mouse immune thrombocytopenia | Lewis BJB, Binnington B, Blacquiere M, Spirig R, Käsermann F, Branch DR | 2021 | eJHaem | View Mechanism of increased efficacy of recombinant Fc-?TP-L309C compared to IVIg to ameliorate mouse immune thrombocytopenia | Researchers | Basic research |
Evidence of SARS-CoV-2 Infection in Cells, Tissues, and Organs and the Risk of Transmission Through Transplantation | Gaussen A, Hornby L, Rockl G, O’Brien S, Delage G, Sapir-Pichhadze R, Drews SJ, Weiss MJ, Lewin A | 2021 | Transplantation | View Evidence of SARS-CoV-2 Infection in Cells, Tissues, and Organs and the Risk of Transmission Through Transplantation | Health care providers | Clinical research |
The SSC platelet immunology register of VITT and VIITP: Toward standardization of laboratory and clinical parameters | Choi PY, Grace RF, Therese Ahlen M, Nazy I, Sachs UJ, Arnold DM, McKenzie SE, Althaus K, Sharma R, Bakchoul T | 2021 | J Thromb Haemost | View The SSC platelet immunology register of VITT and VIITP: Toward standardization of laboratory and clinical parameters | Researchers | Benchmarking and standard setting |
ResearchUnit: Intravenous albumin is not associated with improved outcomes in cardiac surgery patients | Bartoszko J | 2021 | Blood.ca website | View ResearchUnit: Intravenous albumin is not associated with improved outcomes in cardiac surgery patients | Health care providers | Clinical research |
Evidence of SARS-CoV-2 Infection in Cells, Tissues and Organs and the Risk of Transmission Through Transplantation | Gaussen A, Hornby L, Rockl G, O'Brien S, Delage G, Sapir-Pichhadze R, Drews SJ, Weiss MJ, Lewin A | 2021 | Transplantation | View Evidence of SARS-CoV-2 Infection in Cells, Tissues and Organs and the Risk of Transmission Through Transplantation | Health care providers | Clinical research |
International survey on Helicobacter pylori testing in patients with immune thrombocytopenia: Communication of the platelet immunology scientific and standardization committee | Vishnu P, Duncan J, Connell N, Cooper N, Lim W, Rodeghiero F, Tomiyama Y, Grace RF, Bakchoul T, Arnold DM | 2021 | J Thromb Haemost | View International survey on Helicobacter pylori testing in patients with immune thrombocytopenia: Communication of the platelet immunology scientific and standardization committee | Health care providers | Benchmarking and standard setting |
Terminal half-life of FVIII and FIX according to age, blood group and concentrate type: Data from the WAPPS database | Versloot O, Iserman E, Chelle P, Germini F, Edginton AN, Schutgens REG, Iorio A, Fischer K | 2021 | J Thromb Haemost | View Terminal half-life of FVIII and FIX according to age, blood group and concentrate type: Data from the WAPPS database | Researchers | Clinical research |
Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis | Siemieniuk RA, Bartoszko JJ, Díaz Martinez JP, Kum E, Qasim A, Zeraatkar D, Izcovich A, Mangala S, Ge L, Han MA, Agoritsas T, Arnold D, Ávila C, Chu DK, Couban R, Cusano E, Darzi AJ, Devji T, Foroutan F, Ghadimi M, Khamis A, Lamontagne F, Loeb M, Miroshnychenko A, Motaghi S, Murthy S, Mustafa RA, Rada G, Rochwerg B, Switzer C, Vandvik PO, Vernooij RW, Wang Y, Yao L, Guyatt GH, Brignardello-Petersen R | 2021 | BMJ | View Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis | Researchers | Clinical research |
Rapport de surveillance 2020 | O'Brien S | 2021 | Blood.ca website | View Rapport de surveillance 2020 | Health care providers | Benchmarking and standard setting |
Anaphylactic transfusion reactions and IgA deficiency | Khandelwal A, Clarke G, Goldman M | 2021 | Blood.ca website | View Anaphylactic transfusion reactions and IgA deficiency | Health care providers | Benchmarking and standard setting |
Current Understanding of the Relationship between Blood Donor Variability and Blood Component Quality | Hadjesfandiari N, Khorshidfar M, Devine DV | 2021 | Int J Mol Sci | View Current Understanding of the Relationship between Blood Donor Variability and Blood Component Quality | Blood operators | New or improved product or process |
Diagnostic approach to the adult with unexplained thrombocytopenia | Arnold D, Cuker A | 2021 | UptoDate | View Diagnostic approach to the adult with unexplained thrombocytopenia | Health care providers | Benchmarking and standard setting |
Proposal of the Definition for COVID-19-Associated Coagulopathy | Iba T, Warkentin TE, Thachil J, Levi M, Levy JH | 2021 | J Clin Med | View Proposal of the Definition for COVID-19-Associated Coagulopathy | Health care providers | Clinical research |
How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice | Ting J, Yeung K, Paes B, Chan AKC, Petropoulos JA, Banfield L, Bhatt MD | 2021 | Blood Coagul Fibrinolysis | View How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice | Health care providers | Clinical research |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard | Saeed S, O’Brien SF, Abe K, Yi Q-L, Rathod B, Wang J, Fazel-Zarandi M, Tuite A, Fisman D, Wood H, Colwill K, Gingras A-C, Drews SJ | 2021 | PLoS One | View Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard | Health care providers | Benchmarking and standard setting |
Using Blood Wisely One Year Later – Ontario Hospitals Stepping Up to the Challenge | Day D, Lin Y | 2021 | Ontario Regional Blood Coordinating Network September 2021 Newsletter | View Using Blood Wisely One Year Later – Ontario Hospitals Stepping Up to the Challenge | Health care providers | Benchmarking and standard setting |
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial | Bégin P, Callum J, Jamula E, Cook R, Heddle NM, Tinmouth A, Zeller MP, Beaudoin-Bussières G, Amorim L, Bazin R, Loftsgard KC, Carl R, Chassé M, Cushing MM, Daneman N, Devine DV, Dumaresq J, Fergusson DA, Gabe C, Glesby MJ, Li N, Liu Y, McGeer A, Robitaille N, Sachais BS, Scales DC, Schwartz L, Shehata N, Turgeon AF, Wood H, Zarychanski R, Finzi A, Marceau D, Huang A, Carr H, Lin Y, Lall R, Graham C, Arsenault C, Sales V, Sidhu D, Semret M, Hamm C, Arhanchiague E, Solh Z, Srour N, Soliman K, Yee C, Laroche V, Nahirniak S, Greenaway C, Pai M, Côté A, Tsang JLY, Cserti-Gazdewich C, Talbot D, Poulin S, Guimaraes R, Rushton-Marovac M, Langlois A, Ning S, Shih A, Boileau M, Singh H, Ledingham D, Ponnampalam A, Yan M, Prokopchuk-Gauk O, Poirier A, Girouard G, Pavenski K, Drouin O, Harris D, Durand M, Rimmer E, Ovakim D, Ménard F, Cuccarolo G, Carruthers J, Lucier K, Arsenault V, Auclair M-C, Avram M, Brassard M, Cerro S, Martinez V, Morin J, Saint-Jacques M, Veillette M, Armali C, Kron A, Modi D, Duncan J, Justumus P, John MS, St-Onge G, Hadzi-Tosev M, Dion P-M, McGillivary L, de Moulliac AV, Nyman SA, Perilli S, Van Vliet PJ, Lane S, Pavenski K, Pereira R, Sirotich E, Abelson J, Greene S, Khandelwal A, Thakar S, Longo S, Anand SP, Benlarbi M, Bourassa C, Boutin M, Descôteaux-Dinelle J, Gendron-Lepage G, Goyette G, Laumaea A, Medjahed H, Prévost J, Richard J, Kaufmann D, Brunet-Ratnasingham E, Chaumont N, Drebot M, Robinson A, Mendoza E, Dimitrova K, Manguiat K, Phillipson C, Chan M, Evans D, Lin J, Boyer L, Cloutier M, Drouin M, Ducas É, Dussault N, Fournier M-J, Landy P, Nolin M-È, Perreault J, Tremblay T, Nazy I, Xie F, Liu D, Wong M, Silverio G, Walkus K, Barton M, Haveman K, Mueller D, Scott A, Moher M, Wood G, Roarty T, Auld F, Carney G, Thomson V, Onell R, Walley K, Donohoe K, Brunk C, Hernandez G, Jacobucci T, Lazosky L, Mann P, Raval G, Zampieri LA, Sekhon M, Wright A, James N, Chang G, Chen R, Deol K, Gantioqui J, Larsen E, Ramdin N, Roche M, Rosinski K, Sham L, Storms M, Gillrie M, Mahe E, Suryanarayan D, Ugarte-Torres A, Robinson T, Gibbs M, Hewsgirard J, Holmes M, McCarthy J, Ody M, Doucette K, Sligl W, Sonpar A, Robertson K, Narayan J, Ravindran L, Stewart B, Zapernick L, Lee S, Sy E, Wong A, Gryzb K, Craddock S, Fuchs D, Myrah D, Sunny S, Harding SR, Kogilwaimath S, Hodgson N, Johnson D, Meier S, Thomson K, Heendeniya A, Houston B, Kenyan Y, Lother S, Olafson K, Rush B, Wuerz T, Solvason D, Albensi L, Alias S, Choi N, Curtis L, Hutmacher M, Kashani H, Lane D, Marten N, Pronyk-Ward T, Rigaux L, Silva R, Tays Q, Naidu R, Mathews J, Mai M, Miceli V, Molson L, Radhakrishnan G, Schaefer L, Haddad M, Landry S, Chernish R, Kruisselbrink R, Liu T, Jeromin J, Siddiqui A, Girolametto C, Krokoszynski K, Main C, Fox-Robichaud A, Rochwerg B, Kruja E, Ellingham D, Sampat D, Tang N, Leto D, Karunakaran M, Ricciuto D, Fusco K, Ghate T, Robinson H, Ball I, Shalhoub S, Slessarev M, Silverman M, Nano E, Bentall T, Campbell E, Kinney J, Parvathy S, Fera E, Delfa AL, Nadarajah J, Solow H, Mendoza E, Engel K, Monaco D, Kononow L, Suntharalingam S, Fralick M, Munshi L, Saeed S, Hajjaj O, Hsu E, Ali K, Duan E, Farjou G, Jenson L, Salib M, Patterson L, Anant S, Ding J, Jomy J, Das P, Geagea A, the Concor-Study Group | 2021 | Nat Med | View Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial | Health care providers | Clinical research |
Concentré de recherche: Traitement périopératoire des patients atteints de thrombocytopénie immunitaire : comparaison de l’eltrombopag et des immunoglobulines intraveineuses | Arnold DM | 2021 | Blood.ca website | Health care providers | Clinical research | |
High sub-zero organ preservation: A paradigm of nature-inspired strategies | William N, Acker JP | 2021 | Cryobiology | View High sub-zero organ preservation: A paradigm of nature-inspired strategies | Researchers | Basic research |
Complete Genome Sequence of Staphylococcus aureus PS/BAC/169/17/W, Isolated from a Contaminated Platelet Concentrate in England | Paredes C, Chi SI, Flint A, Weedmark K, McDonald C, Bearne J, Ramirez-Arcos S, Pagotto F, Baltrus DA | 2021 | Microbiol Resour Announc | View Complete Genome Sequence of Staphylococcus aureus PS/BAC/169/17/W, Isolated from a Contaminated Platelet Concentrate in England | Researchers | Benchmarking and standard setting |
An international comparison of anti-SARS-COV-2 assays used for seroprevalence surveys from blood component providers | Lewin A, Drews SJ, Lieshout-Krikke R, Erikstrup C, Saeed S, Fady H, Uzicanin S, Custer B, O’Brien SF, the Surveillance Risk Assessment Policy tVS-gotI, Transfusion Transmitted Infectious Diseases Working Party | 2021 | Vox Sang | View An international comparison of anti-SARS-COV-2 assays used for seroprevalence surveys from blood component providers | Blood operators | Benchmarking and standard setting |
Double high-dose immunoglobulin for ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia | Huang CT, Hsu SY, Wang CH, Tseng WJ, Yang CY, Ng CJ, Warkentin TE, Cheng MH | 2021 | Thromb Res | View Double high-dose immunoglobulin for ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia | Researchers | Clinical research |
The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study | Cho JH, Rajbhandary S, van Buren NL, Fung MK, Al-Ghafry M, Fridey JL, Dy BA, Ziman A, Schreiber GB, Gammon RR, Reik R, Stubbs JR, van Buskirk CM, Kamel H, Townsend MJ, Zeller MP, Gottschall JL | 2021 | Transfusion | View The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study | Blood operators | Benchmarking and standard setting |